FDA Approves Clinical Trial of Tuberculosis Vaccine for Fibromyalgia

EpicGenetics announced on 9/5/18 that the U.S. Food and Drug Administration (FDA) has given approval to the Massachusetts General Hospital for a human clinical trial of BCG (an inexpensive generic vaccine used globally to prevent tuberculosis) to treat fibromyalgia.